Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies
Download
Download
Download
Full text for this resource is not available from the Research Repository.
Export
Ridgway, Harry, Moore, Graham J, Gadanec, Laura Kate 
ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Hoffmann, Weronika, Węgrzyn, Katarzyna, Vassilaki, Niki, Mpekoulis, George, Zouridakis, Marios, Giastas, Petros, Vidali, Veroniki P ORCID: 0000-0001-9020-8726, Kelaidonis, Konstantinos, Matsoukas, Minos-Timotheos ORCID: 0000-0002-4642-8163, Dimitriou, Marios, Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X, Tsiodras, Sotirios ORCID: 0000-0002-0463-4321, Gorgoulis, Vassilis G, Karakasiliotis, Ioannis, Chasapis, Christos T ORCID: 0000-0002-8728-6245 and Matsoukas, John ORCID: 0000-0001-5554-2964
(2024)
Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.
Expert Opinion on Therapeutic Targets, 28 (5).
pp. 437-459.
ISSN 1472-8222
Dimensions Badge
Altmetric Badge
| Item type | Article |
| URI | https://vuir.vu.edu.au/id/eprint/48946 |
| DOI | 10.1080/14728222.2024.2362675 |
| Official URL | https://www.tandfonline.com/doi/full/10.1080/14728... |
| Subjects | Current > FOR (2020) Classification > 3204 Immunology Current > FOR (2020) Classification > 3214 Pharmacology and pharmaceutical sciences Current > Division/Research > Institute for Health and Sport |
| Download/View statistics | View download statistics for this item |
CORE (COnnecting REpositories)